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ABSTRACT
Mitochondria participate in metabolism and signal-
ing. They adapt to the requirements of various cell
types. Publicly available expression data permit to
study expression dynamics of genes with mitochon-
drial function (mito-genes) in various cell types, con-
ditions and organisms. Yet, we lack an easy way of
extracting these data for mito-genes. Here, we intro-
duce the visual data mining platform mitoXplorer,
which integrates expression and mutation data of
mito-genes with a manually curated mitochondrial
interactome containing ∼1200 genes grouped in 38
mitochondrial processes. User-friendly analysis and
visualization tools allow to mine mitochondrial ex-
pression dynamics and mutations across various
datasets from four model species including human.
To test the predictive power of mitoXplorer, we quan-
tify mito-gene expression dynamics in trisomy 21
cells, as mitochondrial defects are frequent in tri-
somy 21. We uncover remarkable differences in the
regulation of the mitochondrial transcriptome and
proteome in one of the trisomy 21 cell lines, caused
by dysregulation of the mitochondrial ribosome and
resulting in severe defects in oxidative phosphory-
lation. With the newly developed Fiji plugin mito-
Morph, we identify mild changes in mitochondrial
morphology in trisomy 21. Taken together, mitoX-
plorer (http://mitoxplorer.ibdm.univ-mrs.fr) is a user-
friendly, web-based and freely accessible software,
aiding experimental scientists to quantify mitochon-
drial expression dynamics.
INTRODUCTION
Enormous amounts of transcriptomic data are publicly
available for exploration. This richness of data gives us the
unique opportunity to explore the behavior of individual
genes or groups of genes within a vast variety of different
cell types, developmental or disease conditions or in differ-
ent species. By integrating these data in a sophisticated way,
we may be capable to discover new dependencies between
genes or processes.
Specific databases are available for mining and exploring
disease-associated data, such as The Cancer Genome Atlas
(TCGA, https://portal.gdc.cancer.gov/) (1), or the Interna-
tional Cancer Consortium Data Portal (ICGC, https://dcc.
icgc.org/) (2). Especially cancer data portals allow users to
perform deeper exploration of expression changes of indi-
vidual genes or gene groups in different tumor types ((1–
3); for a review on available cancer data portals, see (4)).
Expression Atlas (https://www.ebi.ac.uk/gxa/home) on the
other hand provides pre-processed data from a large variety
of different studies in numerous species (5). Indeed, the ma-
jority of transcriptomic datasets are not related to cancer
and are stored in public repositories such as Gene Expres-
sion Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/)
(6), DDBJ Omics Archive (https://www.ddbj.nig.ac.jp/gea/
index-e.html) (7), or ArrayExpress (https://www.ebi.ac.uk/
arrayexpress/) (8). Currently, it is not straightforward to in-
tegrate data from these repositories without at least basic
programming knowledge.
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Next to extracting reliable information from -omics
datasets, it is equally important to support interactive data
visualization. This is a key element for a user-guided ex-
ploration and interpretation of complex data, facilitating
the generation of biologically relevant hypotheses––a pro-
cess referred to as visual data mining (VDM, reviewed e.g.
in (9)). Therefore, essentially all online data portals provide
graphical tools for data exploration.
What is fundamentally lacking is a user-centric, web-
based and interactive platform for data integration of a set
of selected genes or proteins sharing the same cellular func-
tion(s). The benefits of such a tool are evident: first, it would
give us the possibility to explore the expression dynamics
and the presence of mutations in this set of selected genes
across many different conditions, tissues and species. Sec-
ond, by integrating data using enrichment techniques, for
instance with epigenetic data or by network analysis using
the cellular interactome(s), it would allow us to identify the
mechanisms that regulate the expression dynamics of the
selected gene set.
One interesting set of genes are mitochondria-associated
genes (mito-genes): in other words all genes, whose encoded
proteins localize to mitochondria and fulfill their cellular
function within this organelle. Mito-genes are well-suited
for such a systematic analysis, because we have a relatively
complete knowledge of their identity and can categorize
them according to their mitochondrial functions (10). This
a priori knowledge can help us in mining and exploring the
expression dynamics of mito-genes and functions in various
conditions and species.
Mitochondria are essential organelles in eukaryotic cells
that are required for producing cellular energy in form of
ATP and for numerous other metabolic and signaling func-
tions (10). Attributable to their central cellular role, mito-
chondrial dysfunctions were found to be associated with a
number of human diseases such as obesity, diabetes, neu-
rodegenerative diseases and cancer (11–15). However, mi-
tochondria are not uniform organelles. Their structural and
metabolic diversity, both of which influence each other, has
been well described in literature (16–20). This mitochon-
drial heterogeneity in different tissues is reflected in their
molecular composition (21). The total number of proteins
that contribute to mitochondrial functions and localize to
mitochondria is currently not precisely known and might
differ between tissues and species (22,23). Yet, based on
proteomic data from several organisms, it is likely that mi-
tochondria contain >1000 proteins (23–30). Mitochondria
have their own genome, whose size in animals is between
11 and 28 kb (31). Most metazoan mitochondria encode 13
essential proteins of the respiratory chain required for ox-
idative phosphorylation (OXPHOS), all rRNAs of the small
and largemitochondrial ribosomal subunits, as well asmost
mitochondrial tRNAs (32). All other proteins found in mi-
tochondria (mito-proteins) are encoded by genes in the nu-
cleus; the protein products of these nuclear-encoded mito-
chondrial genes (NEMGs) are transported to and imported
into mitochondria.
Based on data from mitochondrial proteomic studies or
genome-scale prediction of mito-proteins, several electronic
repositories of the mitochondrial interactome have been
created (24,33–36), though they often lack a proper func-
tional assignments of mito-proteins. Moreover, proteomic
studies describing the mitochondrial proteome can suffer
from a high false-positive rate (23), whereas computational
prediction or machine learning in most cases lack experi-
mental confirmation (37). As a consequence, none of the
published mitochondrial interactomes available to date can
be taken without further manual curation. Moreover, these
lists are not integrated with any available data analysis tool
to explore mitochondrial expression dynamics under vary-
ing conditions or in different tissues or species.
In this study, we present mitoXplorer, a web-based,
highly interactive visual data mining (VDM) platform de-
signed to specifically mine the dynamics of a manually cu-
rated gene set with mitochondrial functions in transcrip-
tome, proteome, as well as mutation-based data. To achieve
this, mitoXplorer integrates -omics data with our hand-
curated mitochondrial interactomes for currently four dif-
ferent model species. With mitoXplorer, we can explore the
expression dynamics, aswell asmutations ofmito-genes and
their associated mitochondrial processes (mito-processes)
across a large variety of different -omics datasets without
the need of programming knowledge. MitoXplorer pro-
vides users with dynamic and interactive figures, which in-
stantly display information on mitochondrial gene func-
tions and protein-protein interactions. Users can analyze
publicly available data stored in our mitoXlorer database
or upload their own data for integration with our hand-
curated mitochondrial interactome. In order to demon-
strate the analytical and predictive power of mitoXplorer
and to experimentally verify mitoXplorer predictions, we
generated transcriptome and proteome data from aneu-
ploid cell lines, carrying trisomy 21 (T21), themost common
chromosome abnormality in humans which is also known
to cause substantial mitochondrial dysfunctions (38). We
used mitoXplorer to analyze and integrate our data with
publicly available trisomy 21 data. MitoXplorer enabled us
to predict respiratory failure in one of our T21 cell lines,
whichwe experimentally confirmed, thus demonstrating the
predictive power of mitoXplorer.
MATERIALS AND METHODS
Implementation of mitoXplorer
Web interface of mitoXplorer (front-end). The web inter-
face of mitoXplorer at the front-end allows users to access,
interact and visualize data from its database, including the
interactome and expression/mutation data. The interactive
elements and visualizations on mitoXplorer are all built
with Javascript, a dynamic programming language that en-
ables interactivity on webpages by manipulating elements
through DOM (Document Object Model). DOM is a rep-
resentation of document, such as HTML, in a tree struc-
ture, with each element as a node or an object. Through
Javascript and its libraries, visualizations in mitoXplorer
can react to users’ action and dynamically change the prop-
erties (size, color, coordinates) of web elements and display
interactivity. All the visualization components in mitoX-
plorer described below are modular by design and can be
deployed individually or incorporated into web platforms
easily.
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Mitochondrial Interactome (D3––data binding and selec-
tion). The visualization of the interactome is created with
the implementation of a Javascript library, D3 (d3.js) (39).
D3 (data-driven documents) is capable of binding data, usu-
ally in JSON (Javascript-oriented notation) format, to the
elements of the DOM so that their properties are entirely
based on given data. In the Interactome View, D3 creates
an SVG (Scalable Vector Graphic) element for each gene
within the DOM in the form of a bubble, with sizes and col-
ors dependent on the associated log2 fold change (log2FC)
values. The coordinates of bubbles are also calculated ac-
cording to the data (e.g. the largest one being at the cen-
ter) so that the layout of the whole interactome is visually
appealing. Upon hovering over any bubble (gene), D3 se-
lects the element and passes additional data bound to that
element to the corresponding web element (sidebar) for dis-
play.
Comparative plot (D3––transition and sorting). The com-
parative plot combines three interdependent visualizations
(scatterplot, bar chart and heatmap) built upon D3. Apart
from data-binding and selection, these visualizations ex-
ploit the functionality of D3 for transition and sorting
through its API. In the scatterplot, genes are displayed as
nodes, whose colors and positions again depend on the data
(log2FC). When another mito-process is selected at the bar
chart, D3 updates the data bound to the node and the prop-
erties of the nodes are changed. The transition (changes
in color and position) is smooth and gives users the im-
pression that the visualization is truly dynamic and inter-
active. D3 can manipulate not only the elements, but also
the data bound to the elements. Upon clicking the dataset
or gene names on the heatmap, the data can be sorted ac-
cordingly and an index is assigned to each element (tile on
the heatmap) to indicate its position.
Hierarchical clustering (mpld3––visualization in Python im-
plemented in D3). The heatmap displaying the results of
hierarchical clustering is built with mpld3, a Python library
that exports graphics made with Python’s Matplotlib-based
libraries to JSON objects that can be displayed on web
browsers. Mpld3 benefits from D3’s data-binding property
and allows users to create a plugin that interacts with the
data on the visualization. The advantage of using mpld3
is that analyses and visualizations made in Python can be
directly translated to JSON and deployed in Javascript on
webpages without re-programming. In the case of hierar-
chical clustering, since libraries for both clustering analysis
and visualization of results in a heatmapwith a dendrogram
are available in Python (described below), it is exported to
JSON with mpld3 and a Javascript tooltip plugin that al-
lows users to select data or display information with D3.
Principal component analysis (three.js––3D visualization).
The visualization of the result of Principal Component
Analysis (PCA) is 3-dimensional, with each dimension rep-
resenting one of the first three principal components (PCs).
This is achieved through the implementation of three.js, a
Javascript library that enables animated 3D graphics to be
created and displayed in a web browser. It starts with build-
ing a ‘scene’, or a canvas, on which 3D objects will be cre-
ated. Then a ‘camera’ is set up that controls the view of
objects on the scene from the users’ perspective, such as
the field of view (width, height, depth) and its ratio; and
a ‘renderer’ that renders the scene at short time intervals so
objects are displayed as animated objects (either they are
animated by themselves or moved around on the scene by
users). Objects of different texture, geometry and color can
now be added to and rendered on the scene. Finally, the
scene with objects is attached to the DOM of a webpage
to become visible. In the PCA visualization, each dataset
is represented and rendered as a small sphere, with coordi-
nates (x, y, z) depending on the values of its first three PCs,
and colors on the grouping of that dataset.When users drag
around on the canvas or zoom in or out, all objects are re-
rendered in such a way that the scene appears to be a 3-
dimensional space.
MitoXplorer database (back-end). A MySQL database
hosted at the back-end of mitoXplorer contains the interac-
tomes of mito-genes, including the mito-process, gene on-
tology and the interactions between gene products; and the
expression and mutation data from public databases. Each
entry of the expression and mutation data has a foreign link
to the interactome and file directory (dataset table). This en-
sures that the expression and mutation data will be updated
together with the interactome, or when a dataset is updated
or deleted. Users can upload their own differential expres-
sion and/or mutation data, which will be processed and in-
tegrated with the interactome by extracting mito-genes, and
stored in the mitoXplorer database for up to 7 days.
Data analysis and communication between front- and back-
end. A Python application serves as a bridge between the
front- and back-end ofmitoXplorer. Upon the users’ request
to access the database or perform analysis at the web in-
terface, an AJAX-asynchronous call directed to the Python
application is made, so the request can be performed in the
background and the webpage is updated without reloading.
The Python application then processes the request by con-
necting to the MySQL database and analyzes the data re-
trieved from it. The application also handles the user up-
loads (e.g. data cleaning) before saving it to the MySQL
database. The main libraries used by the Python applica-
tion for analysis include: (i) Scikit-learn: a machine learn-
ing library that provides tools for PCA, to perform dimen-
sionality reduction on the expression of all mito-genes and
of each mito-process. The first three principal components
are extracted for each dataset. (ii) SciPy: a mathematical li-
brary that provides modules for hierarchical clustering, to
calculate 2D distance matrices between genes and between
datasets based on expression values, for each mito-process.
(iii) Seaborn: a statistical visualization library built on top
of SciPy to create heatmaps from the results. All the results
are produced in JSON format, which are then sent via the
HTTP protocol back to the front-end and visualized with
Javascript.
The usage of mitoXplorer does not require installation
or programming knowledge. Documentation and tutori-
als are available online and on GitLab (https://gitlab.com/
habermannlab/mitox). MitoXplorer is also available for
download and installation on a local server, if users wish to
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build their own gene list and apply the interactive features
and database of mitoXplorer, which stores the available ex-
pression and mutation data for all genes. Setup instructions
are also available on the mitoXplorer GitLab repository,
as is a docker version of mitoxplorer (https://gitlab.com/
habermannlab/mitox, branch docker-version).
Processing of public transcriptomic and proteomic data.
Proteomic and transcriptomic data from Ku¨hl (40), as well
as Liu (41), Letourneau (42), Sullivan (43) and Spletter (44)
were uploaded as provided by the authors.
Public NGS datasets downloaded from GEO which did
not already contain differential expression data in the form
of log2FC and P-value were analyzed according to avail-
able pre-analyzed data: datasets with available raw read
counts were analyzed using DESeq2 (version 3.9, (45)).
These included data from Chowdhury (46) and Garipler
(47). Datasets for which only the normalized read counts
were available, the log2FC was calculated for each sample,
using the corresponding wild-type samples as control (or
the mean of normal samples if there were no paired sam-
ples) following best-practice guidelines. We applied this to
data from TCGA (1), downloaded from the NCI GDC
Data Portal (https://portal.gdc.cancer.gov/)), from Fleis-
cher (48) and from Huang (49). Finally, microarray time-
course data of yeast meisosis (GEO accession: GSE75257)
were analyzed with GEO2R (50).
Metadata of the datasets (e.g. cell types, analysis pipeline
and genome version used for mapping) were also down-
loaded and stored in the mitoXplorer database. The links
to the experiments for each dataset are available at the
DATABASE summary page of mitoXplorer.
Transcriptomics and proteomics of aneuploid cell lines. The
proteome analysis of the trisomic cell lines was previously
described (51,52).
The raw reads from RNA-sequencing were processed to
remove low quality reads and adapter sequences (using
TrimGalore v0.4.5 (https://www.bioinformatics.babraham.
ac.uk/projects/trim galore/), which uses Cutadapt (53))
and FastQC (Andrew, S. (2010) FastQC: a quality con-
trol tool for high throughput sequence data. http://
www.bioinformatics.babraham.ac.uk/projects/fastqc)), and
aligned to the human reference genome (version hg19) with
TopHat2 (v2.0.11) (54). Cuffdiff from the Cufflinks package
(v2.2.1) (55) was used with standard parameters to calculate
the expression difference between two samples (aneuploid
versus diploid) of multiple replicates and test the statisti-
cal significance. Transcriptome and proteome information
are available in public repositories: NGS data have been de-
posited in NCBI’s Gene Expression Omnibus and are ac-
cessible through GEO series accession number GSE102855
and GSE131249.
Cell culture and treatment. The human cell line RPE-1
hTERT (referred to as RPE) was a kind gift by Stephen
Taylor (University of Manchester, UK). Human HCT116
cells (referred to as HCT) were obtained from ATCC
(No. CCL-247). Trisomic cell lines were generated by
microcell-mediated chromosome transfer as described pre-
viously (51). The A9 donor mouse cell lines were pur-
chased from the Health Science Research Resources Bank
(HSRRB), Osaka 590-0535, Japan. All cell lines were main-
tained at 37◦C with 5% CO2 atmosphere in Dulbecco´s
modified Eagle’s medium (DMEM) containing 10% fetal
bovine serum (FBS), 100 U penicillin and 100 U strepto-
mycin.
MitoTracker staining and imaging. Mitochondria were
stained in 96-well plates. The cells were incubated for 30min
at 37◦C with 100 nMMitoTracker deep Red FM (M22426,
Invitrogen®) dye prior to fixation. Cells were fixed with 3%
PFA in DMEM for 5 min at room temperature. After wash-
ing twice with 1xPBST, plates were stored with 1× PBS con-
taining 0.01% sodium azide. Plates were stored at 4◦C in
the dark. Imaging was carried out on an inverted Zeiss Ob-
server.Z1 microscope with a spinning disc and 473, 561 and
660 nm argon laser lines. Imaging devices were controlled,
and images were captured, stored and processed with the
SlideBook Software in Fiji (56). The images were captured
automatically on multiple focal planes (step size: 700 nm)
with a 40× magnification air objective.
Metabolic profiling of wild-type and T21 cell lines. RPE
and HCT cells and their T21 derivatives were seeded at 25
000 or 36 000 cells/well respectively, on XF96 cell plates
(Seahorse Bioscience, Agilent Technologies), 30 h before
being assayed. Optimization of reagents as well as CCCP
and digitonin titrations were performed as described by the
manufacturer’s protocols (Seahorse Bioscience). The exper-
iments were performed using the mitochondrial and gly-
colytic stress test assay protocol as suggested by the man-
ufacturer (Seahorse Bioscience, Agilent Technologies). By
employing the Seahorse Bioscience XF Extracellular Flux
Analyzer, the rate of cellular oxidative phosphorylation
(oxygen consumption rate (OCR)) and glycolysis (cellular
proton production rate (PPR)) were measured simultane-
ously.
For OCR measurement, DMEM media was supple-
mented with 25 mM glucose, 1 mM pyruvate and 2 mM
glutamine. Basal rate was recorded and additions for the
mito stress test were as follows: 1.5 M oligomycin, CCCP,
2 M rotenone + 4 M antimycin A. For PPR measure-
ment, DMEM media was supplemented with 2 mM glu-
tamine. Basal rate was recorded and additions for the gly-
colysis stress test were as follows: 10 mM glucose, 1.5 M
oligomycin and 100 mM 2-deoxyglucose.
For intact cells, the CCCP concentrations were 7 and 1.5
M for RPE1 and HCT116 cells, respectively. The assays
of intact cells were performed in 96-well plates with at least
10 replicates per cell line. For the permeabilized RPE1 cell
lines, the CCCP and digitonin concentrations were 10 and
40 M, respectively. For OCR measurement, Mannitol–
sucrose buffer (MAS) was prepared according to Seahorse
Biosciences. For permeabilization, digitionin was added to
MAS buffer together with the respective respiratory sub-
strates: 10 mM pyruvate/2 mMmalate, 10 mM succinate/2
M rotenone or 0.5 mM TMPD/2 mM ascorbate/2 M
antimycin A. Basal respiration was recorded, as were addi-
tions of 4 mM ADP, 1.5 M oligomycin, CCCP and 2 M
rotenone ± 4 Mantimycin A or 20 mMNa-azide. The as-
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says in permeabilized cells were performed in poly-D-lysine-
coated 96-well plates with at least five replicates per cell line.
Normalizationwas performedwith theCyQuant cell pro-
liferation assay kit (Life Technologies) in the same plate
used for the assay of intact cells; and in a parallel plate for
the permeabilized cells. Data analysis was done according
to (57).
The mitoMorph plugin for morphological characterization of
mitochondria by image analysis. Classification and mea-
surement of mitochondria were performed using the soft-
ware ImageJ (58), complemented with all the default plug-
ins provided by Fiji (56) and with the additional plugin Fea-
tureJ. A set of functions were developed to assist the user in
the preparation and analysis of the data, either in interactive
or batch processing mode.
Using this toolset, after all the cells of interest were man-
ually outlined in each image, the mitochondria were seg-
mented and characterized. For each processing step, the al-
gorithms used are reported as described in ImageJ, and their
parameters are specified in physical units.
The images were pre-processed by first suppressing the
background signal (rolling ball background subtraction,
kernel radius: 2.5 m) and then enhancing the mitochon-
dria signal (Laplacian of Gaussian, smoothing scale: 1 m,
followed by contrast limited adaptive histogram equaliza-
tion, CLAHE, kernel size: 2.5 m). Mitochondria candi-
dates were obtained by segmentation, using Yen threshold-
ing algorithm (59), and subjected to classification based on
a set of determined features.
Objects that were too small were excluded from the anal-
ysis, and the remaining ones were assigned to one of four
categories: filamentous networked (filaments), puncta, rods
and swollen (60). Objects that were quasi-round, compact
in intensity, and larger than the puncta were classified as
swollen. All objects with an intermediate phenotype be-
tween fragmented puncta and network of filaments were
classified as rods.
Classification was performed by sequentially verifying
different selection criteria, one set for each class, based
on the following measured features: area (A), aspect ratio
(AR), circularity (C), solidity (S), minimum Feret diame-
ter (here indicated as minimum linear extension, MLE) and
longest shortest-path (here indicated as extension, E).While
all the other measures are directly derived from the segmen-
tation, the extension is measured as the longest shortest-
path between any two end points in the skeleton derived
from the segmentation. The selection criteria are evaluated
sequentially as reported in Supplementary Table S1.
Wewould like to note that analysis ofmitochondrialmor-
phology on projected images is limited, as mitochondrial
structures might not be resolved properly.
Image analysis using mitoMorph and data processing. Im-
age processing and analysis was done in Fiji. Image stacks
were Z-projected, cells were manually selected and the re-
sulting images were saved for further batch processing using
mitoMorph. Resulting network statistics of mitochondrial
features for each individual cell were used for further pro-
cessing (Supplementary Table S1). All statistical processing
and data visualization ofmitoMorph results was done using
RStudio (v1.1.423, R-version: 3.6.1). Data were averaged
over both clones of the two T21 cell lines.
RESULTS
The outline of the mitoXplorer web-platform is illustrated
in Figure 1: at the back-end, manually curated mitochon-
drial interactomes from human, mouse, Drosophila and
budding yeast, as well as expression andmutation data from
these four species are stored in a MySQL database (details
on the implementation of the back-end are available in Ma-
terials and Methods, as well as Supplementary Figure S1).
The user interacts with themitoXplorer web-platform via
the front-end, which offers different visualization and anal-
ysis methods. Users can either browse stored public data or
upload their own data.
The mitochondrial interactomes
The main component of mitoXplorer is the mitochondrial
interactome. Its accurate annotation and completeness are
essential for performing a meaningful mitoXplorer-based
analysis. To establish mitochondrial interactomes, we have
assembled and manually curated lists of genes with anno-
tated mitochondrial processes (mito-processes). Currently,
the interactomes of four organisms are available on mi-
toXplorer: Homo sapiens (human),Mus musculus (mouse),
Drosophila melanogaster (fruit fly) and Saccharomyces cere-
visiae (budding yeast). We started from published mito-
chondrial proteomic data (27,61) for the selected species
and manually cleaned the data, as well as supplemented
missing mito-genes in the following way: we removed obvi-
ous false-positives from the datasets; these included mainly
proteins for which there is compelling evidence in litera-
ture that they are not localized to mitochondria. Next, we
supplemented likely missing genes from the proteomic data
using information from Mitocarta (24), KEGG (62) infor-
mation of genes associated with mitochondrial pathways,
as well as orthologs across species from the four proteomic
datasets. To establish whether a protein in question is pri-
marily localized tomitochondria or not, we relied on several
sources: (i) evidence from the literature on a specific gene;
(ii) information from the respective gene entry at NCBI
(63), Flybase (64) or the Saccharomyces genome database
(SGD) (65); (iii) information from the GeneCards database
(66); (iv) information from UniProt (67). We supplemented
the lists with all non-coding genes present in the mitochon-
drial genomes, namely all mitochondrial rRNAs, as well as
tRNAs. After manual curation, we obtained 1229 human,
1222 mouse, 1139 Drosophila and 988 budding yeast mito-
genes. We grouped the genes in mito-processes using con-
trolled vocabulary. In addition to purelymitochondrial pro-
cesses, we added cytosolic processes coupled to mitochon-
drial functions, includingGlycolysis, the Pentose phosphate
pathway, Apoptosis or the regulation of transcription of
nuclear-encoded mitochondrial genes (Transcription (nu-
clear)). This resulted in a total of 38 mito-processes (Ta-
ble 1). We selected the correct mito-process for each gene
primarily using information from the same sources men-
tioned before (NCBI gene entry, Flybase, SGD,GeneCards,
UniProt, KEGG). According to our current annotation,
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H. sapiens 1229 mito-genes
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S. cerevisiae 988 mito-genes
- grouped into 38 mitochondrial processes
- connected by STRING protein-protein interactions 
manually curated, annotated 
mitochondrial interactome 
differential expression data & 
mutation data
pubic data user data
M. musculus
H. sapiens
S. cerevisiae
D. melanogaster
Figure 1. Setup of the mitoXplorer web-based visual data mining platform. A manually curated, annotated mitochondrial interactome represents the
central part of the mitoXplorer software, for which we have assembled 1229 mito-genes in human, 1222 mito-genes in mouse, 1139 mito-genes in fruit fly
and 988 mito-genes in budding yeast in 38 mitochondrial processes (mito-processes). We have connected gene products using protein-protein interactions
from STRING (69). Publicly available expression and mutation data from repositories such as TCGA or GEO are provided for data integration, analysis
and visualization and are stored together with species interactomes in a MySQL database. Users can provide their own data, which are temporarily
stored and only accessible to the user. A set of Python-based scripts at the back-end of the platform handle data formatting, integration and analysis
(Supplementary Figure S1). The user interacts with mitoXplorer via several visual interfaces to analyze, integrate and visualize his private, as well as public
data. Four interactive visualization interfaces are offered: (i) the Interactome View allows at-a-glance visualization of the entire mitochondrial interactome
of a single dataset (see Figure 2); (ii) comparative plots, consisting of a scatterplot and a sortable heatmap allows comparison of up to six datasets, whereby
a single mito-process is analyzed at a time (see Figure 3); (iii) hierarchical clustering allows comparison of a large number of datasets which are clustered
according to their expression values. Hierarchical clustering plots are zoom-able and interactive (see Figure 4); (iv) principal component analysis displays
PCA-analyzed datasets in 3D, providing filtering and grouping functions. There is in principle no limit to the number of datasets that can be analyzed
using PCA (see Figure 5).
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one gene is part of only a single mito-process. We acknowl-
edge that this annotation strategy has limitations, as a mito-
gene can be part of more than one mito-process: as an
example, in KEGG, the human gene GPI is part of the
pathways Glycolysis, as well as Pentose phosphate path-
way. In GeneCards, GPI is primarily associated with Gly-
colysis, thus we assigned it to the mito-process Glycolysis.
For other genes, the existing annotations were less clear and
we had to decide on the primary process a gene should be-
long to. For some mito-processes, we solved this by intro-
ducing the ontologically higher ranked term: for instance,
mito-genes involved in fatty acid (FA) metabolic pathways
can be associated with either the biosynthesis or degrada-
tion of FAs, or both: genes implicated in both processes
were allocated to the term that would rank higher, namely
Fatty acid metabolism. Genes involved in the transport of
molecules across themitochondrial membranewere divided
into three groups: those involved in import & sorting of
all mito-proteins that are encoded in the nuclear genome
and translated in the cytosol into mitochondria; those that
are part of the mitochondrial carrier family (68); and fi-
nally those transmembrane proteins that are involved in mi-
tochondrial transmembrane transport and cannot be as-
sociated with either of the other two groups. Finally, to
complete the mitochondrial interactome and reveal poten-
tial interactions between mito-processes, we added protein-
protein interaction information from STRING (69) for all
mito-genes.
Since we cannot guarantee that our current annotation is
either complete or exempt from mis-annotations, and with
the goal of nucleating a community-based effort to further
complete and improve the annotation of the mitoXplorer
mito-interactomes, we provide a ‘FEEDBACK’ page. Users
can submit comments and suggestions on genes and their
annotations using this page, suggest new genes and new
mito-processes or provide any other feedback.
Mito-genes of human, mouse, Drosophila and budding
yeast annotated with mito-processes are available in Sup-
plementary Table S2A–D. The mito-interactomes can also
be downloaded from the INTERACTOME page of mitoX-
plorer. These manually curated and annotated interactomes
enable ameaningful analysis and visualization ofmitochon-
drial expression dynamics ofmito-genes andmito-processes
by comparing differential expression of two or more condi-
tions in mitoXplorer.
The mitoXplorer expression and mutation database
To foster the analysis ofmitochondrial expression dynamics
and mutations, mitoXplorer hosts expression and mutation
data from public repositories in a MySQL database.
Expression data encompass analyzed data of differen-
tially expressed genes from RNA-seq studies and are avail-
able in the form of log2 fold change (log2FC) and P-value.
One differential dataset thus includes two experimental con-
ditions with all replicates. Mutation data include analyzed
data of identified SNPs of one sample against a publicly
available reference genome or transcriptome.
Pre-analyzed public data are taken as provided by the
authors of the respective study: information on software
and genome version used for read mapping, as well as soft-
ware and settings used for differential expression analysis
can generally be found at the GEO-link of the respective
project listed on the DATABASE page. We have ensured
that only high-quality data with replicates, as well as a prop-
erly described analysis strategy are available in the mitoX-
plorer database. If only raw read counts were available, we
analyzed the data using state-of-the-art software (DESeq2
(45), for details see Methods). Finally, whenever only nor-
malized read counts were available, which is typical for large
population-based studies, we calculated log2FC according
to (70). It should be noted that due to the heterogeneity of
the available formats of the provided data, the algorithms
and their settings, as well as the genome version used for
read mapping might differ for available projects in mitoX-
plorer.
The largest public resource imported into mitoXplorer
covers publicly available expression data of human can-
cers from The Cancer Genome Atlas (TCGA) (1). We have
included all paired samples. This resulted in a total of
523 differential datasets from six different cancer types:
kidney cancer (KIRK), breast cancer (BRCA), liver can-
cer (LIHC), thyroid cancer (THCA), lung cancer (LUAD)
and prostate cancer (PRAD). Changes in mitochondrial
metabolism have been described in many cancer types
(for a review, see (71)). As mitoXplorer is thus far the
only resource that allows a focused analysis of mito-genes
across different cancer types or patient groups, this resource
should be especially useful to shed light on the expression
dynamics of mito-genes in cancer and to classify the mito-
chondrial metabolic profiles of tumor types and sub-types.
Users can moreover integrate proprietary data with differ-
ential expression data from different tumor types and sub-
types.
We also uploaded expression data from cultivated fibrob-
lasts of healthy human donors ranging from 1 to 94 years of
age (48) (GEO accession: GSE113957). Since decline in mi-
tochondrial quality and activity are well-known contribu-
tors to age-related conditions and diseases (72), this dataset
should help uncover the contribution of altered mito-gene
expression dynamics to the ageing process.
We made available several datasets from mouse knock-
out studies: we uploaded differential transcriptomic and
proteomic data of five different mouse conditional heart
knock-out strains of genes involved in mitochondrial
replication, transcription and translation (40) (Lrpprc,
Mterf4, Tfam, Polrmt, Twnk (Twinkle), (GEO accession:
GSE96518)). These data are especially helpful in unravel-
ing the transcriptional and post-transcriptional effects on
mito-genes upon disruption of gene expression at different
levels in mitochondria.
Furthermore, we added data from a mouse model of a
known mitochondria-associated condition, the Barth syn-
drome. Barth syndrome patients develop severe cardiomy-
opathy (73). This syndrome is caused by mutations in or
loss of the TAZ gene coding for the protein Tafazzin which
is involved in cardiolipin biosynthesis (74). Failure of en-
zyme activity of Tafazzin leads to altered mitochondrial
membrane composition, structure and metabolism (74,75).
We provide differential expression data of Taz knock-out
mouse embryonic fibroblasts (MEFs) compared to wild-
type in normoxic and hypoxic conditions generated by
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Table 1. Mito-processes and number of associated mito-genes in human, mouse, Drosophila and budding yeast
Mito-process Human Mouse Drosophila Budding yeast
Amino acid metabolism 81 79 67 44
Apoptosis 56 55 43 6
Bile acid synthesis 2 2 7 0
Calcium signaling & transport 23 23 12 4
Cardiolipin biosynthesis 6 6 5 5
Fatty acid biosynthesis & elongation 22 22 15 13
Fatty acid degradation & beta-oxidation 30 31 26 9
Fatty acid metabolism 15 13 20 8
Fe-S cluster biosynthesis 25 26 19 23
Folate & pterin metabolism 13 13 9 13
Fructose metabolism 7 7 3 14
Glycolysis 38 37 35 33
Heme biosynthesis 9 9 9 5
Import & sorting 51 51 61 55
Lipoic acid metabolism 3 3 4 3
Metabolism of lipids & lipoproteins 34 36 17 14
Metabolism of vitamins & co-factors 17 18 19 9
Mitochondrial carrier 46 45 46 23
Mitochondrial dynamics 61 59 48 39
Mitochondrial signaling 18 18 10 11
Mitophagy 21 21 13 11
Nitrogen metabolism 9 9 16 7
Nucleotide metabolism 15 15 12 23
Oxidative phosphorylation 167 164 173 115
Oxidative phosphorylation (MT) 13 13 13 9
Pentose phosphate pathway 7 7 6 14
Protein stability & degradation 27 27 20 25
Pyruvate metabolism 26 25 24 12
Replication & transcription 51 52 32 50
ROS defense 34 34 30 24
Transcription (nuclear) 24 24 25 6
Translation 185 184 192 210
Translation (MT) 24 24 24 37
Transmembrane transport 20 20 21 24
Tricarboxylic acid cycle 21 22 29 26
Ubiquinone biosynthesis 9 9 9 12
Unknown 12 12 20 46
UPRmt 7 7 4 6
Chowdhury et al. (46) (GSE accession: GSE119775); these
data should help reveal the effect of Tafazzin loss of func-
tion during hypoxia.
To extend mitoXplorer to other model organisms, we
added data from D. melanogaster, namely expression data
from 185 wild-derived, inbred strains (males and females)
from the Drosophila Genetics Reference Panel (DGRP2)
(49): this set of lines stems from an out-crossed population
in Raleigh, North Carolina. These wild-derived fly strains
display a substantial quantitative genetic variation in gene
expression. The availability of these data onmitoXplorer al-
lows a focused analysis of mito-genes to elucidate whether
mitochondrial expression dynamics is equally impacted in
these strains.
Moreover, we have uploaded data from a recently pub-
lished systematic study of flight muscle development in
D. melanogaster (44) (GEO accession: GSE107247). This
enables the analysis of mitochondrial expression dynam-
ics during the development and differentiation of a tis-
sue that is highly dependent on an efficient mitochon-
drial metabolism and especially ATP production for proper
functioning.
Regarding budding yeast, we imported data from a time-
course expression profiling experiment of meiosis of a syn-
chronized cell culture (Hanlon SE, Lieb JD (unpublished),
GEO accession: GSE75257), allowing users to mine the ex-
pression dynamics of mito-genes over 12h of sporulation.
This project is the only microarray-based dataset we have
uploaded on mitoXplorer.
Finally, we uploaded data from Protein Phosphates 2A
(PP2A) yeast deletion strains; these strains show a dimin-
ished response of nuclear gene expression associated with
mtDNA damage compared to wild-type (47) (GEO acces-
sion: GSE52242). This dataset should help shed light on the
role of the conserved protein phosphatase PP2A in protect-
ing cells from mtDNA damage.
To verify mitoXplorer predictions experimentally, we use
data from human trisomy 21: we provide data from human
trisomy 21 patients (GEO accession numbers: GSE55426;
GSE79842; (42,43)), from trisomy 21 studies in mouse
(GSE5542 (42), GSE79842 (43)), as well as differential
datasets generated in the course of this study from human
trisomic cell lines (11 datasets) which have been partially
published elsewhere (51,52) (GEO accessions: GSE39768;
GSE47830; GSE102855). These transcriptomic, as well as
proteomic datasets should help understand the role of mi-
tochondria and the mitochondrial metabolism in trisomy
21.
All available data can be viewed and accessed from the
mitoXplorer DATABASE web-page.
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User-provided expression and/or mutation data
Researchers can upload and explore their own data in
mitoXplorer, given that they originate from one of the
species contained in the mitoXplorer platform. Data must
be pre-analyzed. Differential expression data must contain
the dataset ID (describing the experimental condition), the
gene name and the log2FC. Optional values include the
P-value, as well as the averaged read counts (or intensi-
ties) of the replicates of the compared conditions. Muta-
tion data must contain the dataset ID, gene name, the chro-
mosome, the position, as well as reference and alternative
allele. Optional values include the effect, as well as the
consequence of the mutation. Users have the option to ei-
ther generate their own data according to the format de-
scribed on our website. We recommend to follow the best-
practice-guidelines available for analyzing transcriptomic
or proteomic data prior to uploading data to mitoXplorer
(see for instance (76,77) for differential expression analy-
sis or (78) for variant calling). Alternatively, users may use
the RNA-seq pipeline for differential expression analysis
and mutation calling that we provide at https://gitlab.com/
habermannlab/mitox rnaseq pipeline/.
The entire list of genes from a study should be uploaded
to the platform for several reasons: first, a restriction to only
differentially expressed or mutated genes will suppress links
between proteins in the interactome; second, an integration
of user data with publicly provided data is difficult with in-
complete datasets; third, mitoXplorer will automatically se-
lect the mito-genes from the user data. Uploaded data will
be checked for correct formatting and integrated with the
interactome of the chosen species. User data are only visi-
ble to the owner and are stored in the mitoXplorer MySQL
database for 7 days. Users can integrate their own data with
available public data on mitoXplorer to perform various
analyses and visualizations as described below (Figure 1).
Analysis and visualization tools in mitoXplorer
The mitoXplorer web-platform provides a set of powerful,
easy-to-read and highly interactive visualization tools to an-
alyze and visualize public, as well as user-provided data by
VDM (Figure 1): an Interactome View to analyze the over-
all expression and mutation dynamics of all mito-processes
of a single dataset containing differentially expressed genes
between two conditions and potential mutations in mito-
genes; the Comparative Plot, consisting of an interactive
scatterplot, as well as an interactive heatmap for compar-
ing up to six datasets; theHierarchical Clustering, as well as
the Principal Component Analysis for comparative analysis
of many datasets.
INTERACTOME VIEW
The InteractomeView can be used to get an at-a-glance view
of the overall expression dynamics of all mito-processes of
a single dataset of differentially expressed mito-genes and
potential mutations (Figure 2A). It allows users to identify
the most prominently changedmito-processes or -genes in a
dataset. The genes are grouped according to mito-processes
and displayed in the process they are assigned to. The Inter-
actomeView is highly dynamic and can be adjusted by users
to their needs.
When the Interactome View is launched, each mito-
process is primarily shown as a grey circle with elements
colored in grey, blue and/or red, indicating up- or down-
regulated genes within the process, respectively (Figure 2A).
Thus, mito-processes with the most up- or down-regulated
genes can be quickly identified.
When clicking on a process name, its circle opens up to
display all its member genes as bubbles. The size of the bub-
ble relates to the strength of the differential regulation while
the color indicates up- (blue) or down- (red) regulation of
the gene (Figure 2B). If information about mutations is in-
cluded in the dataset, this is indicated by a thicker, black
border of the gene bubble.
Hovering over a gene will display the gene name, its func-
tion, its mito-process, the log2FC and the P-value of the
differential expression analysis, as well as potential muta-
tions in the information panel (Figure 2C). If a gene phys-
ically interacts with other mito-genes, hovering over it or
over the process circle will in addition display these connec-
tions (Figure 2C). Thus, the user is immediately informed
about the location and connectivity of the protein of in-
terest within the mitochondrial interactome. Users can also
search for specific genes using the ‘FIND A GENE’ box at
the top of the page.
The Interactome View can be launched by clicking on the
‘eye’ symbol next to dataset names from the ANALYSIS
page of mitoXplorer, after having chosen the organism, the
project and the dataset. Alternatively, users can access sin-
gle datasets from the DATABASE page of the platform, by
clicking on the eye symbol of a listed dataset after having
chosen a species, as well as a project. A new page will be
opened for the InteractomeView, which allows opening and
comparing multiple datasets at the same time. This is espe-
cially useful for comparing the overall expression change of
mito-processes of multiple datasets.
COMPARATIVE PLOT
The Comparative Plot visualization combines several in-
teractive graphs to analyze one mito-process, allowing the
comparison of up to six datasets. It includes a scatterplot
with a dynamic y-axis, as well as an interactive heatmap
at the bottom of the page. The mito-process to be visual-
ized can be selected in the process panel (Figure 3A). Red
and blue coloring of the dots and the heatmap indicates the
directionality of differential expression (blue: upregulated;
red: down-regulated); bright blue, larger gene bubbles in the
scatterplot indicate mutations, if available from the dataset.
This Comparative Plot offers an overview of the expression
dynamics of all members of one mito-process for up to six
individual datasets and thus can be helpful in identifying
co-regulated genes e.g. in time-course data, patients or mul-
tiple mutant datasets.
Hovering over a gene bubble, or over a tile in the heatmap
will again display the respective associated information of
the gene in the information panel (gene name, function,
mito-process, log2FC,P-value, potentialmutations) (Figure
3B). The heatmap can be sorted according to the dataset,
as well as the differential expression values within one
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gkz1128/5651332 by Bibliothèque de l'université de la M
éditerranée user on 04 D
ecem
ber 2019
10 Nucleic Acids Research, 2019
A
B C
Interactome View
+
Translation
-
Translation
Oxidative
Phosphorylation
Amino acid
metabolism
Oxidative
Phosphorylation
Translation
Oxidative
phosphorylation
Fatty acid
degradation &
beta-oxidation
ROS defense
mito-Carrier
Pyruvate
metabolism
Metabolism
of lipids &
lipoproteins
Fe-S cluster
biosynthesis
Folate & pterin
metabolism
mito-Dynamics
Translation (mt)
Glycolysis
Apoptosis
Import &
sorting
Nucleotide
metabolism
Oxphos (mt)
mito-Signaling
Tricarboxylic
acid cycle Ubiquinone
biosynthesis
Fatty acid biosynthesis
& elongation
Metabolism
of vitamins &
co-factors
Transmembrane
transport
Amino acid
metabolism
Fatty acid
metabolism
Protein stability
& degradation
Replication &
Transcription
Heme 
biosynthesis
Transcription
(nuclear)
UPRmt
Ca2+ signaling
& transport
Mitophagy
+
Unknown
+
Fructose 
metabolism
+
Nitrogen 
metabolism
+
Lipoic acid
metabolism
+
Bile
acid
synthesis
+
Cardiolipin
biosynthesis+
Pentose
phosphate
pathway
Figure 2. Interactome View of the mitoXplorer platform. (A) Overview of all mito-processes of one dataset. A process can either be shown as one circle
with colored segments according to the number of dysregulated genes, or upon clicking on the process, by showing all individual genes being part of this
process, see (B): by clicking on the process Translation or the adjacent ‘+’, the circle is replaced by individual bubbles representing genes of this process.
Clicking on the process again, or on the adjacent ‘–‘ will revert to the circular display. (C) Hovering over a gene bubble will display the name of the gene
and associated information (gene name, description, chromosomal location, mitochondrial process, accession numbers, as well as log2 fold change, P-value
and observed mutations), as well as all connections to mito-genes in other processes. Compared were the retinal epithelial cell line RPE1 (RPE) wild-type
to RPE1 with Trisomy 21 (RPE T21).
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Figure 3. Comparative Plot of the mitoXplorer platform. (A) The Comparative Plot display is composed of a scatterplot, sortable heatmap and a bar chart
for the selection of mito-processes. The scatterplot shows the log2 fold change (y-axis) and the datasets (x-axis). Each bubble represents one gene, whereby
red bubbles indicate down-regulated, and blue ones upregulated genes. The process to be shown can be selected by clicking on the process name in the
bar chart next to the scatterplot, the chosen process being indicated on its top. In this case, TCA cycle was chosen. The heatmap at the bottom shows the
individual genes and the datasets, whereby the genes are colored according to their log2 fold change (indicated at the bottom of the plot). (B) Hovering
over a gene bubble (or a gene tile in the heatmap) will display available information (in case of fly: gene name, mitochondrial process, gene description,
chromosomal location, gene symbol, as well as log2 fold change, P-value and observed mutations). (C) The heatmap is sortable by log2 fold change (as
indicated by the pointer in C), as well as by dataset. Clicking on one of the datasets will sort the heatmap according to the log2 fold change of all genes
in this dataset, as is illustrated here. Clicking on one of the genes will sort the heatmap according to its log2 fold changes across different datasets. The
time-series study of developing flight muscle (44) was used to demonstrate the functionality of this visualization method.
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dataset (Figure 3C). The Comparative Plot is especially use-
ful for performing a detailed, comparative, mito-process
based analysis of differential expression dynamics between
different datasets.
We applied this analysis method to visualize differential
expression data from a time-series study of flight muscle de-
velopment during pupal stages in Drosophila (44) (Figure
3). While enrichment analysis has revealed a general pos-
itive enrichment of processes like Tricarboxylic acid cycle
(TCA Cycle) in the course of flight muscle development,
mitoXplorer identifies 12 genes of TCA cycle that are co-
regulated. This group of genes is strongly upregulated be-
tween 0 and 16 h after puparium formation (APF), when
myoblasts divide and fuse to myotubes. The same group of
genes is consecutively down-regulated in two phases at time-
points 30–48 h and 72–90 h APF, when myotubes differen-
tiate to mature muscle fibers. This is surprising as in ma-
ture muscle fibers the TCA cycle should be important for
proper functioning. Their strong induction between the first
two time-points could be responsible for downregulation at
later stages.
THE HEATMAP: HIERARCHICAL CLUSTERING
Hierarchical Clustering visualization allows the analysis of
up to 100 datasets, analyzing one process at a time. This cre-
ates a heatmap with mito-genes, as well as -datasets, which
are clustered according to the log2FC using hierarchical
clustering (Figure 4 a). The results are displayed as a clus-
tered heatmap, with a dendrogram indicating the distance
between datasets or between genes.
Hovering over a gene will display its associated informa-
tion, as well as dataset information in the information panel
(Figure 4B). The user can furthermore zoom into parts
of the heatmap to get a more detailed view of the data.
The heatmap is particularly useful for discovering groups of
similarly regulated mito-genes or datasets within one mito-
process.
We applied this visualization tool to display transcrip-
tome and proteome data from a recent, systematic study of
mouse conditional knock-out strains for five genes involved
in mitochondrial replication (Twinkle (Twnk)), mtDNA
maintenance (Tfam), mito-transcription (Polrmt), mito-
mRNA maturation (Lrpprc) and mito-translation (mTerf4)
(40). Interestingly, the expression dynamics of the mito-
chondrial transcriptomes and proteomes in heart tissue did
not cluster together for the mutants, suggesting strong post-
transcriptional effects or protein stability changes of mito-
proteins upon the loss of any of these genes. In accordance
with this, the expression of some mito-genes in the process
Pyruvatemetabolism that is shownhere differs on transcrip-
tome and proteome level. This demonstrates the usefulness
of hierarchical clustering and the heatmap display in iden-
tifying the correlation or divergence between genes as well
as datasets.
PRINCIPAL COMPONENT ANALYSIS
A larger number of datasets can be compared using Prin-
cipal Component Analysis (PCA), either for an individual
mito-process, or considering all mito-genes together (Fig-
ure 5A). In PCA, the expression value (e.g. log2FC) of each
gene is considered as one dimension, and each dataset repre-
sents one data point. In the resulting 3DPCAplot, the three
axes represent the first three principal components and each
bubble represents one dataset. The PCA is again interactive.
Mito-processes can be selected via a drop-down menu on
the top of the page. The plot can be turned and moved in
3D and has a zooming function.
Hovering over a bubble will give the information asso-
ciated with an individual dataset in the information panel,
including the values of the first three principal components
(Figure 5B). The information differs for each project cho-
sen.
Individual datasets can be selected and colored via the
dataset panel next to the plot (Figure 5C). For instance with
data fromTCGA the filter and coloring can be used to high-
light or to limit the plot to data from different tumors, dif-
ferent tumor stages or according to any other additional in-
formation provided. The PCA is especially useful for an-
alyzing a large number of datasets and displaying specific
trends in sub-groups.
We used the PCA plot to visualize data from the TCGA
for four cancer types stored in mitoXplorer in Figure 5A,
whereby the colors of the bubbles represent the different tu-
mor types. The plot clearly highlights the variance of the
different tumor types. In particular, kidney and liver cancer
are highly distinct with respect to the first three components
of all mito-genes (Figure 5A).
GROUPS function
In order to allow a more detailed, gene-centered analysis of
correlated datasets, we added the possibility to select and
group datasets in the Heatmap and the PCA views. Groups
of datasets can be compared against each other with the
Comparative Plot, whereby the log2FC is averaged over the
datawithin a group. This functionality is useful, for instance
when different groups of donors with similar expression
patterns should be compared to each other.
We demonstrate the usability of the GROUPS function
in Supplementary Figure S2, where we analyzed the aver-
aged expression patterns of ageing human fibroblasts from
healthy donors from 1 to 94 years of age (48). A first analysis
using the PCAplot revealed that individuals which are older
than 80 years were separated from the rest of the donors
(Supplementary Figure S2A).
We next applied the GROUPS function to analyze dif-
ferent age groups using the mitoXplorer Comparative Plot.
We chose to group individuals based on age, whereby we
generated six age groups from age 40 to 100 years. As the
age group 80–90 years showed two distinct clusters, we split
this group in individuals that cluster with younger donors
(g1), and those that cluster with the age group over 90 (g2).
Our analysis using mitoXplorer GROUPS helped reveal a
strong downregulation of a substantial number of mito-
genes in nearly all mito-processes starting from the age of
85 (Supplementary Figure S2B), suggesting a general mito-
chondrial decline in old age.
Taken together, mitoXplorer provides a versatile, inter-
active and integrative set of tools to visualize and analyze
the expression dynamics as well as mutations of mito-genes
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Figure 4. Hierarchical Clustering and heatmap plot of the mitoXplorer platform. Hierarchical Clustering of expression data results in a so-called heatmap.
(A) Heatmap of transcriptome and proteome data of mouse knock-out strains of genes involved in mitochondrial replication, DNA-maintenance, tran-
scription andRNAprocessing (taken from (40)). Data are clustered according to genes, as well as datasets. Gene tiles are colored according to their log2 fold
change. At the top of the heatmap, the user can choose the mito-process to be displayed. (B) Hovering over one of the gene tiles will display information on
the gene, such as the gene name, mito-process, log2 fold change, P-value and – if available – observed mutations. The heatmap is also zoom-able by clicking
on the magnification glass at the bottom of the plot, so that large datasets can be visualized and analyzed efficiently. Datasets can be selected within the
heatmap by grouping. To do this, first a group name has to be defined; second, the datasets belonging to this group have to be selected by clicking on one
of the gene boxes of the dataset. This process can be repeated and the resulting groups can then be analyzed using Comparative Plots (see Supplementary
Figure S2).
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and mito-processes, facilitating a detailed understanding of
observed changes at a molecular level.
Analyzing transcriptomes of mitochondria-associated health
conditions using mitoXplorer
To demonstrate the analytical and predictive power of mi-
toXplorer, we explored available transcriptome data from
health conditions associated with mitochondrial functions.
We first performed mitoXplorer analysis of data from a
mouse model of Barth syndrome (46), a mitochondrial dis-
order caused by mutations of the Taz gene which encodes
the protein Tafazzin. Second, to show that we could verify
mitoXplorer predictions experimentally, we analyzed our
set of trisomy 21 data using mitoXplorer (51,52).
Analyzing the effects of Tafazzin loss of function in normoxic
and hypoxic conditions using mitoXplorer
The Taz gene which encodes the cardiolipin acyl transferase
Tafazzin is required for the remodeling of cardiolipin, an
essential lipid component of the mitochondrial inner mem-
brane (79). Loss of Tafazzin function leads to an abnor-
mal fatty acid composition and a decrease in cardiolipin
levels, resulting in abnormal mitochondrial morphology
and dynamics, decreased stability of respiratory supercom-
plexes and increased oxidative stress (see (80) and references
therein). Loss of Tafazzin function is also the primary cause
of Barth syndrome (73), a rare, recessive, X-linked disorder
that is characterized by cardiomyopathy, skeletal myopathy,
growth retardation and neutropenia (81). Cardiolipin has
been implicated inmanymitochondrial processes, including
mitochondrial protein import, mitochondrial carrier func-
tion, mitochondrial morphology and dynamics, respiratory
chain function and metabolism (see (82) and references
therein). Chowdhury et al. (46) subjected Tafazzin-mutant
mouse embryonic fibroblasts (MEFs) to hypoxic stress to
unravel themechanismof impaired hypoxia-response in this
cellularmodel of Barth syndrome. They observed that in hy-
poxia, a reduction of ROS levels in Tafazzin-deficient cells
prohibited the induction of the NF-B pathway, resulting
in reduced Hif1 expression levels and subsequently the in-
ability to respond to hypoxia.
Using the mitoXplorer Interactome View, we first could
show that loss of Tafazzin function leads to a substan-
tial perturbation of mito-gene expression in normoxic con-
ditions (Supplementary Figure S3A), among which are
themito-processesMitochondrial dynamics andMitochon-
drial carrier (Figure 6A, B). In hypoxia, the expression pro-
file of Tafazzin-deficient MEFs showed markedly different
expression dynamics from wild-type cells (Supplementary
Figure S3B).
In agreement with the findings from Chowdhury et al.,
using mitoXplorer we found Hif1 down-regulated in Taz-
deficient cells under normoxic and hypoxic conditions,
while it was induced in hypoxia in wild-type cells (Figure
6C). Using Harmonizome (83), we also found a number of
predicted and verified Hif1 target genes, some of which
were de-regulated under hypoxic conditions in the Tafazzin-
deficient cells (marked by an asterisk in Figure 6A–D). Next
to Hif1 we found Yap1 de-regulated with the same expres-
sion dynamics. Yap1 is part of the Hippo signaling pathway
and was shown to be stimulated in hypoxia (84), where it
binds to and stabilizes Hif1. As shown in Figure 6C, Yap1
was down-regulated upon loss of Tafazzin function in nor-
moxic and hypoxic conditions, while it was upregulated in
hypoxia in wild-type cells.
mitoXplorer analysis also revealed the failure of induc-
ing RelA in hypoxia in Tafazzin-deficient cells. This tran-
scription factor is a member of the Nf-B family and was
shown to be induced and activated early in hypoxia to mod-
ulate NF-B target gene expression. The NF-B depen-
dent response to hypoxia was equally impaired upon loss
of Tafazzin function.
Chowdhury and colleagues proposed that reduced ROS
levels in response to hypoxia prevent proper NF-B acti-
vation in Tafazzin-deficient cells. We thus investigated the
expression dynamics of mito-genes in ROS defense using
mitoXplorer and found that theMitochondrialMethionine
Sulfoxide Reductase B2 (MsrB2) was strongly induced in
Tafazzin-deficient MEFs (log2FC of 6.67 in normoxic and
5.13 in hypoxic conditions, respectively), whereas MsrB2
levels remained constant in wild-type cells in hypoxia (Fig-
ure 6D). MsrB2 reduces methionine (R)-sulfoxide to me-
thionine and thus decreases reactive oxygen species in the
cell due to its quenching properties; thus, its overexpression
protects cells from oxidative stress (85). Its strong induc-
tion could be responsible for reduced ROS levels observed
in Tafazzin-deficient cells.
In conclusion, usingmitoXplorer we could not only iden-
tify previously described mito-processes affected by loss of
Taffazin in normoxic conditions and confirm expression
changes of Hif1 in Tafazzin-deficient cells in hypoxia. The
expression profiles revealed by mitoXplorer analysis fur-
thermore suggest that loss of Yap1 contributes to the ob-
served phenotype by de-stabilizing Hif1. Moreover, our
analysis usingmitoXplorer indicates that massive induction
of the MsrB2 gene could be responsible for reduced ROS
levels in Tafazzin-deficient cells in hypoxia, leading to a fail-
ure of induction of the NF-B pathway and the transcrip-
tion factor RelA.
Analyzing cell lines carrying trisomy 21 using the mitoX-
plorer platform
We next wanted to experimentally verify predictions made
with mitoXplorer. To this end, we analyzed the tran-
scriptome and proteome of a set of aneuploid cell lines
carrying an extra copy of chromosome 21 (trisomy 21,
T21).Mitochondrial dysfunction has been repeatedly found
in T21 patients, whereby mostly oxidative stress, as well
as––potentially resulting––mitochondrial respiratory defi-
ciency have been shown to contribute to some of the ob-
served clinical features (see for instance (86–99)). Tran-
scriptome studies of different T21 tissues using microarrays
(100–110) and more recently RNA sequencing (42,43,111)
and proteomics (41,112–115) have revealed a complex pic-
ture of gene expression changes, with amarked dissimilarity
in differential expression of mito-genes on mRNA and pro-
tein levels, indicating a potential post-transcriptional reg-
ulatory effect of some mito-genes in T21 (41). Yet, mito-
gene and protein expression data in different tissues or un-
der varying conditions in T21 remain sparse and a coherent
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Figure 6. Mito-gene expression dynamics of Tafazzin-deficient mouse embryonic fibroblasts in normoxic and hypoxic conditions. The mito-processes
Mitochondrial dynamics (mito-Dynamics), Mitochondrial carrier (mito-Carrier), Transcription (nuclear) and ROS defense are shown. (A) Among the
genes involved inmito-Dynamics, the predictedHif1 targetMgarp is strongly down-regulated in Tafazzin-deficient cells and fails to be induced in hypoxia.
Mgarp is required for movement of mitochondria along microtubules during hypoxia (126). (B) The mitochondrial carriers Ucp3, a predicted Hif1 target,
as well as Slc25a45 are differentially regulated in Tafazzin-deficient cells in hypoxia. (C) The transcription factors Hif1, Yap1 (Hippo pathway) and Rela
(NF-B pathway)––all highlighted in red––are differentially regulated in Tafazzin knock-out cells in hypoxia compared to wild-type: they are induced in
hypoxia and are down-regulated in Tafazzin-mutant cells in normoxic, as well as hypoxic conditions. Mitf and Ppara show opposite expression behavior,
being induced in Tafazzin-deficient cells and down-regulated in hypoxia in wild-type cells. (D) The ROS defense gene MsrB2 (marked in red) is strongly
induced in Tafazzin-deficient cells, while it remains constant in hypoxia in wild-type conditions. MsrB2 has ROS quenching properties.
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hypothesis of the underlying mechanisms leading to the mi-
tochondrial deficiencies in T21 patients is still missing.
We used trisomy 21 cell lines derived from either the eu-
ploid human colon cancer cell line HCT116 or from the
retinal pigmented epithelial cell line RPE1, to which an ex-
tra copy of chromosome 21 was added (51). We used two
RPE1-derived and twoHCT116-derived clones trisomic for
chromosome 21 (Supplementary Table S3 a), which were
validated by fluorescent in situ hybridization and by whole
genome sequencing. We used transcriptomic data of the
original euploid RPE1 line and its two trisomic deriva-
tives (RPE T21 clone 1 and 2 (c1, c2) (51)), as well as
for HCT116, and its trisomic derivatives (HCT T21 (c1,
c3)). We included proteomic data for RPE1 and one of
its T21 derivatives (RPE T21 c1). We performed bioinfor-
matic analysis to determine differential expression of the
above conditions (Supplementary Table S3B–E, for details
on bioinformatic data analysis see Materials and Methods)
and uploaded the differential expression data of the tran-
scriptome and proteome on the mitoXplorer platform for
further in-depth, mitochondrial analysis.
Differences between trisomy 21 cell lines
MitoXplorer analysis of data comparing HCT116- and
RPE1-derived T21 cell lines using the Interactome View
revealed that T21 induced strong effects with respect to
the overall expression changes in mito-genes (Figure 7).
HCT T21 showed a subtle, but consistent up-regulation of
mito-genes (Figure 7A). In contrast, RPE T21 cells showed
a strong downregulation of a few genes involved in sev-
eral mito-processes, such as Fatty acid metabolism, Gly-
colysis or Mitochondrial dynamics (Figure 7B). Remark-
ably, quantitative proteome data from RPE T21 c1 cells
suggested that all mitochondria-encoded genes involved
in OXPHOS, as well as the majority of nuclear-encoded
OXPHOS-genes are down-regulated (Figure 7C). In con-
clusion, mitoXplorer analysis facilitated the finding of sig-
nificant differences inmito-gene expression between the dif-
ferent cell lines. Importantly in RPE T21 cells, proteome
data showed a remarkable difference to transcriptome data.
mitoXplorer analysis suggests mitochondrial ribosomal as-
sembly defects in RPE T21 cell lines
To investigate the differences further, we next performed a
more detailed analysis of expression changes in these T21
cell lines using Comparative Plots in mitoXplorer. Tran-
scriptome and proteome data from RPE T21, but not from
HCT T21 cell lines revealed that several subunits of the
small mitochondrial ribosome (mitoribosome) were signif-
icantly down-regulated on either RNA or protein level,
or both (Figure 8A). MRPS21 was strongly reduced on
RNA- and protein-level. The genes MRPS33, MRPS14
and MRPS15 were largely normal on RNA level, while
their protein levels decreased more than 2-fold (log2FC:
MRPS33: -2.147; MRPS14: −1.827; MRPS15: −1.057).
Mitoribosomal subunits are encoded in the nuclear genome
and their protein products are imported into the mitochon-
dria, where they assemble with mitochondrial ribosomal
RNAs to form the large and small subunits of the mitoribo-
some. The mitoribosome is responsible for translating the
13 mt-mRNAs encoded in the mitochondrial genome, all
of which code for key subunits of the respiratory chain re-
quired for OXPHOS (116,117). In accordance with a dis-
rupted mitochondrial translation machinery, all quantifi-
able mitochondria-encoded OXPHOS proteins (Complex
I: MT-ND1 and MT-ND5; Complex IV: MT-CO2) were
severely diminished on protein-, but not on RNA-level in
RPE1 T21 cells (Figure 8B).
Interestingly, 36 of the quantifiable OXPHOS pro-
teins encoded in the nuclear genome were also found
to be down-regulated at the proteome, but not at tran-
scriptome level in RPE T21 cells (Figure 8C). These in-
clude subunits of the NADH dehydrogenase (complex I),
ubiquinol−cytochrome c reductase (complex III) and cy-
tochrome c oxidase (complex IV). It is important to note
that there is no general downregulation of mitochondrial
proteins in these cells and only a few, specific proteins are
strongly down-regulated (Figure 7C). Together, these data
demonstrate the power of mitoXplorer to help identify the
cause of important changes in mito-gene expression, here
the downregulation of mitoribosomal subunits at the tran-
scription level and the resulting consequences, in this case
the downregulation of the majority of OXPHOS proteins.
RPE T21 cells are defective in oxidative phosphorylation
The massive downregulation of OXPHOS proteins in
RPE T21 cells suggests that these cells should suffer from
a severe OXPHOS deficiency. To test this hypothesis exper-
imentally, we analyzed cellular respiration and glycolysis in
T21 cell lines using a Seahorse XF96 analyzer to quantify
oxygen consumption rate (OCR) as an indicator of mito-
chondrial respiration (Figure 9A−D, F), as well as the pro-
ton production rate (PPR) as an indicator of glycolysis (Fig-
ure 9E, G). In intact RPE T21 cells, we indeed observed
dramatically reduced levels of cellular respiration in com-
parison to the diploid control (Figure 9A).
As a complex I deficiency has been reported in trisomy
21 patients (95), we next asked whether RPE T21 cells se-
lectively suffer from a complex I deficiency, or whether the
entire respiratory chain is affected, as suggested by our pro-
teomic data. We used permeabilized cells to test each indi-
vidual complex with the Seahorse analyzer, supplementing
with pyruvate/malate, succinate and TMPD/ascorbate for
assessing complex I, II or IV functionality, respectively. As
expected from our proteomic analysis, RPE T21 cells dis-
played a severe deficiency of the entire respiratory chain
(Figure 9B−D). The glycolytic rate of RPE T21 cells in
the presence of glucose was similar to the diploid control
cells. Inhibition of ATP-production was not able to stimu-
late the cells to a higher glycolytic rate (Figure 9E), which
agrees with the already low OXPHOS levels observed in
these cells. HCT T21 cells, on the other hand, displayed
normal respiration, as well as glycolysis (Figure 9F,G). This
suggests that the respiratory chain, as well as the mitochon-
drial translational machinery is not generally affected in all
T21 cells. Taken together, mitoXplorer helped uncover OX-
PHOS deficiencies in RPE T21 cells, which we verified ex-
perimentally, demonstrating the power of an in-depth anal-
ysis of mitochondrial expression dynamics to identify the
potential molecular cause of the observed phenotype.
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Figure 7. Interactome View of the transcriptome and proteome of cell lines carrying trisomy 21. Trisomy 21 samples were compared against their wild-
type counterpart. Transcriptomic analysis of (A) HCT116 T21 (trisomy 21 against wild-type, c3) and (B) RPE21 T21 (trisomic against wild-type, c1);
(C) proteomic analysis of RPE T21 cells (trisomy 21 against wild-type, c1). Transcriptome changes are different between the two trisomy 21 cell lines
HCT116 and RPE1. Expression changes of HCT T21 cells are mild and genes tend to be upregulated (A), while some genes are strongly down-regulated in
RPE T21 cells (B). The transcriptome (B) and the proteome (C) of RPE T21 cells respond quite differently, with a strong downregulation of components
of the process Oxidative phosphorylation (OXPHOS) at proteome level which is not observed on transcriptome level. Most genes differentially expressed
at transcript level, on the other hand, show no significant changes on proteome level. Red bubbles indicate downregulation, blue ones indicate upregulated
genes. The size of the bubble corresponds to the log2 fold change.
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Figure 8. Scatterplots of Translation, mitochondrial- as well as nuclear components of Oxidative phosphorylation of trisomy 21 cells. (A) In the mito-
chondrial process Translation, MRPS21 is strongly down-regulated on transcriptome level in RPE T21 cells as compared to RPE1 wild-type (wt) cells. No
change is observed in HCT T21 cells. On proteome level, several components of the mitoribosome small subunit (SSU) are down-regulated in RPE T21
cells. (B) Transcript levels of mitochondria-encoded genes of Oxidative phosphorylation (OXPHOS) are not affected, while those genes are strongly dimin-
ished on protein level. (C) A significant number of components of OXPHOS are down-regulated on protein level in RPE T21 cells, while no significant or
only mild reduction can be observed on transcriptome level in trisomy 21 cell lines. Scatterplots are taken from the mitoXplorer Comparative Plot inter-
face. Each bubble represents one gene, light blue dots indicate mutated genes. On the y-axis, the log2 fold change is plotted, the cell lines (transcriptome
of HCT116 T21 (HCT T21) clone 1 (c1) and clone 3 (c3) versus wild-type, as well as transcriptome of RPE1 T21 (RPE T21) clone 1 (c1) and clone 2
(c2) versus wild-type and proteome of RPE1 T21 clone 1 (RPE T21 c1) versus wild-type) are plotted on the x-axis. The gene highlighted in pink has been
selected on the web-server: MRPS21 for the process Translation; MT-CO2 for the process Oxidative phosphorylation (mt); and no gene has been selected
in the process Oxidative phosphorylation.
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Figure 9. Mitochondrial respiration and glycolysis is strongly affected in RPE T21 cells and not affected in HCT T21 cells. (A) Respiration in intact
RPE T21 cells is greatly decreased compared to wild-type. (B–D) Permeabilized RPE T21 cells supplemented for substrates of complex I, II and IV as
indicated in the header of each plot, showed equally dysfunctional OXPHOS, suggesting a general break-down of the respiratory chain. (E) RPE T21
cells do not have any spare glycolytic reserve. Respiration (F), as well as glycolysis (G) is virtually unchanged in HCT T21 cells compared to their wild-
type counterparts. Bright red: RPE T21 clone 1; light red: RPE T21 clone 2; dark red: RPE wild-type; dark blue: HCT wild-type; light blue: HCT T21
clone 1. Measurements of cellular respiration in intact and permeabilized cells, as well as glycolytic potential were done using the Seahorse Bioscience XF
Extracellular Flux Analyzer (Seahorse Biosciences). The experiments were performed using the mitochondrial and glycolytic stress test assay protocol as
suggested by the manufacturer; the rate of cellular oxidative phosphorylation (oxygen consumption rate (OCR)) and glycolysis (cellular proton production
rate (PPR)) were measured simultaneously.
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Quantification of mitochondrial network morphology using
mitoMorph
We further wanted to investigate, if T21 and the defective
OXPHOS had a consequence on mitochondrial morphol-
ogy and the mitochondrial network structure was changed
in T21 cell lines. To quantify mitochondrial morphology in
RPE T21 cells, we stained mitochondria using the Mito-
Tracker Deep Red FM dye. In order to quantify the char-
acteristics of mitochondrial morphology, we developed a
new Fiji plugin for quantification of mitochondrial net-
work features, which we called mitoMorph. MitoMorph is
based on the scripts provided by Leonard et al. (60) for
quantifying mitochondrial network features such as fila-
ments (corresponding to filamentous networked structures
longer than 11 m), rods (corresponding to filamentous
networked structures shorter than 11 m), puncta (corre-
sponding to round structures below a radius of 0.6 m) and
swollen (corresponding to round structures above a radius
of 0.6 m) mitochondrial structures (see Methods for im-
plementation details). MitoMorph reports the percentages
of filaments, rods, puncta and swollen for each individual
cell, as well as for all selected cells in a batch analysis (Fig-
ure 10A, B). Moreover, it provides the lengths and areas
of filaments and rods. Figure 10C−F shows the distribu-
tion of mitochondrial network features for the two wild-
type and T21 cell lines. MitoMorph analysis revealed that
in both backgrounds, T21 cells had fewer mitochondrial fil-
aments than their wild-type counterparts, but instead pos-
sessed a slightly higher number of rods, which was signifi-
cant in HCT T21 cells. Both T21 cell lines had significantly
more swollen structures than their wild-type counterparts.
Length and area distribution of filaments and rods were not
significantly different between thewild-type and the trisomy
21 cells (Supplementary Figure S4A−D). We looked at ex-
pression dynamics of mito-genes associated with the pro-
cess Mitochondrial dynamics using mitoXplorer. The only
gene that is consistently, though onlymildly down-regulated
in both RPE T21 clones is GDAP1 (Supplementary Figure
S5). GDAP1 was shown to regulate the mitochondrial net-
work by promoting mitochondrial fission (118). Its down-
regulation could be contributing to or be a consequence of
the observed phenotype. In conclusion, mitochondrial mor-
phology based on light-microscopy is mildly affected in tri-
somy 21.
Data integration with publicly available trisomy 21 datasets
After discovering this differential OXPHOS defect in our
RPE T21 cell lines, we were interested in the overlap of
the mito-transcriptome and -proteome of RPE T21 cells
with data from trisomy 21 patients. We used proteomic and
transcriptomic data from a monozygotic twin study discor-
dant for chromosome 21 (41,42). In agreement with our
RPE T21 data, systematic proteome and proteostasis pro-
filing of fibroblasts from monozygotic twins discordant for
T21 revealed a significant, although milder downregulation
of the mitochondrial proteome, including proteins involved
in OXPHOS, which is not apparent from transcriptomic
analysis of the same cells (see Supplementary Figure S6A,
B).
We next looked at proteomic data of fibroblasts from 11
unrelated individuals with trisomy 21 (41) (Supplementary
Figure S6C−E). Virtually all T21 patients showed reduc-
tion in at least a few mitochondrial- and nuclear-encoded
subunits of the respiratory chain (Supplementary Figure
S6D, E). However, we could not confirm the strong reduc-
tion of the MRPS21 protein in all individuals. The only
measurable mitoribosome subunit that was consistently,
though in some cases only mildly, down-regulated was
MRPL19 (Supplementary Figure S6C). Taken together,
though the precise molecular mechanisms remain elusive,
our analysis of these datasets withmitoXplorer nevertheless
suggests a post-transcriptional effect leading to reduced ex-
pression levels of proteins involved in OXPHOS in trisomy
21.
DISCUSSION
The web-based mitoXplorer platform for mito-centric data
exploration
MitoXplorer is a practical web tool with an intuitive inter-
face for users who wish to gain insight from -omics data in
mitochondrial functions. It is the first tool that takes ad-
vantage of the breadth of -omics data available to date to
explore expression variability of mito-genes and -processes.
It does so by integrating a hand-curated, annotated mito-
chondrial interactome with -omics data available in public
databases or provided by the user.
MitoXplorer has been conceived and implemented as a
visual data mining (VDM) platform: by iteratively inter-
acting, visualizing and by allowing manipulation of the
graphical display of data, the user can effectively discover
complex data to extract knowledge and gain deeper under-
standing of the data. MitoXplorer provides a set of particu-
larly interactive and flexible visualization tools, with a fine-
grained, function- as well as gene-based resolution of the
data. Clustering, as well as PCA-analysis help in addition to
mine a larger number of -omics data effectively by grouping
datasets with similar expression patterns.
VDM-based knowledge discovery is offered by a large
number of resources and platforms. However, to the best
of our knowledge, no currently available tool allows to ex-
plore expression variation of a specific subset of genes in
a large number of -omics datasets. It permits users to ex-
ploit publicly available transcriptome, proteome or muta-
tion data to study the variation and thus, the adaptability of
a defined gene set in different conditions or species. While
mitoXplorer offers the exploration of mito-genes, we have
designed the platform in such a way that users interested
in a different gene group can download a local version of
mitoXplorer and upload their own interactome, which may
contain any gene group of interest. Thus, mitoXplorer can
be flexibly adjusted to any user-defined gene set.
Identification of putative causes of ROS-downregulation in
Tafazzin-deficient cells using mitoXplorer
We have analyzed data from a mouse model of Barth syn-
drome to demonstrate that mitoXplorer can help identify
de-regulated pathways in mitochondria-associated diseases.
Barth syndrome results from a dis-balance of cardiolipin
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Figure 10. Mitochondrial morphology is slightly changed in trisomy 21 cells. We have stained the mitochondrial network and analyzed the network
morphology, measuring the percentage of filamentous networked (filaments), rods, puncta and swollen using the Fiji plugin mitoMorph. (A) Sample of
mitoMorph analysis of an RPE1 wild-type cell and (B) of an HCT116 wild-type cell. Filamentous networks are highlighted in lilac, rods in green, puncta
(referring to fragmentedmitochondria) are highlighted in orange and swollen ones in blue. The percentage filaments, rods, puncta and swollenmitochondria
are automatically scored and reported to the user. (C) the percentage of filaments is slightly, but significantly reduced in RPE T21, as well as HCT T21
cells compared to wild-type. (D) There is no significant change in the percentage of rods in RPE T21 cells and slightly higher percentage in HCT T21
cells compared to wild-type. (E) The percentage of puncta is unchanged in both T21 cell lines. (F) There are significantly more swollen mitochondria in
both, RPE T21, as well as HCT T21 cells compared to wild-type. Results have been averaged over both clones of each cell line, respectively. Underlying
numerical values are provided in Supplementary Table S1, sample images are shown in Supplementary Figure S7.
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species due to the loss-of-function of the Tafazzin pro-
tein and displays defects in many mitochondrial processes.
Chowdhury et al. have specifically tested the response to
hypoxia of Tafazzin-deficient cells. They have identified re-
duced ROS levels in Tafazzin-deficient MEFs that lead to a
failure to induce the NF-B transcription factor RelA and
finally, the transcription factor Hif1. Using the more com-
prehensive and manually curated mito-interactome of mi-
toXplorer, we could not only confirm the failure of induc-
tion of RelA andHif1.We furthermore propose that failed
induction of the Hippo pathway protein Yap1 which stabi-
lizes Hif1 could contribute to the observed phenotype. Fi-
nally, using mitoXplorer we identified MrsB2 as the puta-
tive cause of lowered ROS levels in Tafazzin-deficient cells,
as this enzyme has ROS-quenching activities, normally pro-
tecting cells from oxidative damage.
Cell type-specific de-regulation of mito-genes in trisomy 21
We experimentally verified mitoXplorer predictions by ex-
pression profiling ofmito-genes in T21 cell lines.Mito-genes
were strongly deregulated in both trisomic cell types tested,
the non-cancerous retinal pigment epithelial cell line RPE1
and the cancer cell line HCT116. Yet, the changes in ex-
pression were quite different in the two cell lines. It is not
unexpected that mito-genes are differentially expressed in
different cell types, reflecting the divergent cellular energy-
and metabolic demands (20). Gene expression is moreover
tightly regulated in a cell-type specific manner by regulat-
ing transcription, translation and the epigenetic state of the
cell. Thus, also divergent and cell-type specific expression
changes of mito-genes upon introduction of an extra chro-
mosome is not surprising.
mitoXplorer assisted in revealing divergent de-regulation of
mitochondrial transcriptome and proteome in trisomy 21
We found a remarkable difference between transcriptome
and proteome levels of mito-genes in RPE T21 cells. In par-
ticular theOXPHOSproteins were strongly down-regulated
at protein, but notmRNA level. This can be explained by es-
sential components of the respiratory chain being encoded
in the mitochondrial genome and thus requiring a func-
tioning mitochondrial replication system, as well as intact
mitochondrial transcription and translation. Thus, there is
as strong post-transcriptional regulation of the mitochon-
drial proteome. In case of the RPE T21 cell line, the disin-
tegration of the mitoribosome and thus a failure of mito-
chondrial translation is likely causative for the downregu-
lation of OXPHOS components on protein-level, possibly
by proteolysis, as the essential mitochondrial subunits are
not produced and thus complexes cannot assemble. This
conclusion is further supported by the fact that we could
not observe a significant difference in mitochondrial tran-
script levels, with somemt-mRNAs even being upregulated;
thus, mtDNA -maintenance, -replication as well as mito-
transcription seem to be unaffected.
MitoXplorer analysis of previously published data of
the mito-proteome of fibroblasts isolated from monozy-
gotic twins discordant for T21, as well as 11 unrelated in-
dividuals with trisomy 21 (41) confirmed a similar post-
transcriptional effect as we found in our T21 model cell
lines. Taken together, our data uncovered a significant post-
transcriptional regulation of themitochondrial processOX-
PHOS in our model system of trisomy 21 that could bring
new insight into the mechanisms of mitochondrial defects
in trisomy 21 patients.
mitoXplorer helped identify mitochondrial ribosomal protein
S21 (MRPS21) as potentially causative forOXPHOS failure
The most notable difference in RPE T21 cells compared
to wild-type is the >10-fold downregulation of mitochon-
drial ribosomal protein S21 (MRPS21) on transcript level,
as well as the downregulation of Mrps21 protein and other
proteins of the small and––to a lesser extend––large mi-
toribosome subunits. Thus, our data suggest that the in-
tegrity of the mitoribosome is compromised, leading to its
disintegration and subsequently, the downregulation of mi-
tochondrial proteins of the respiratory chain. Mrps21 is a
late-assembly component and lies at the outer rim of the
body (or bottom) of the small subunit (SSU) of the mitori-
bosome. Nevertheless, it interacts with a number of other
proteins of the SSU and also directly contacts bases of the
12S rRNA (119,120). Thus, its absence could destabilize the
SSU of the mitoribosome. The two most down-regulated
proteins areMrps33 andMrps14, both of which directly in-
teract with each other and several other proteins in the SSU
and are localized to the head of the SSU. Furthermore, to-
gether with another down-regulated component, Mrps15,
they are proteins that are incorporated late in the mitori-
bosome assembly process (120). This raises the possibility
that late-assembly proteins disintegrate more readily from
the mitoribosome, leading to their enhanced degradation
and thus ribosome malfunction.
Based on promoter analysis using MotifMap (121), po-
tential binding motifs of two transcription factors located
on chromosome 21, GABPA and ETS2, can be found in
the promoter region of the MRPS21 gene. Gabp, which
is also known as nuclear respiratory factor 2, has already
been implicated in mitochondrial biogenesis by regulating
Tfb1m expression (122): its depletion in mouse embryonic
fibroblasts showed reduced mitochondrial mass, ATP pro-
duction, oxygen consumption and mito-protein synthesis,
but had no effect onmitochondrial morphology, membrane
potential or apoptosis. Direct or indirect regulation of mi-
toribosomal proteins could be another regulatory function
of this transcription factor. GABPA is not affected on tran-
scriptome level, but is down-regulated on protein-level in
RPE T21 cells. ETS2 on the other hand has so far not been
implicated in mitochondrial biogenesis or functional regu-
lation.
We see consistent downregulation of proteins involved
in OXPHOS in other trisomy 21 proteomic datasets and
OXPHOS defects have been reported in trisomy 21 before.
MRPS21 seems deregulated only in a few T21 individuals.
Thus, the causes of OXPHOS deficiencies seem to depend
on genomic background or on the cell type studied. Trisomy
21 patients develop different degrees of severity of symp-
toms and it is likely that the genomic variability of chromo-
some 21 contributes to the varying phenotypes (123,124).
In conclusion, while defects in OXPHOS seem a common
phenotype in trisomy 21, their severity as well as the un-
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derlying mechanisms might differ depending on the cellular
model or the genomic background.
Limitations and future developments of mitoXplorer
The proper assembly and annotation of the mito-
interactomes turned out to be a demanding task. While
proteomic studies of mitochondria are available for differ-
ent model species and humans, the data cannot be taken
without manual intervention due to significant numbers
of false-positives and false-negatives. A manual curation
of the data is therefore mandatory. Though we carefully
curated the mito-interactomes used in mitoXplorer, we do
not claim that they are complete or free of false-positives.
We decided to assign one mito-gene with one mito-
process only, as it was the most straightforward solution
to implement. Furthermore, assigning multiple processes to
one gene would artificially increase the mitochondrial inter-
actome, making the analysis also more difficult. Neverthe-
less, the current annotation might not represent all exper-
imentally validated biological functions of a mito-gene. In
future releases, we will therefore consider allowing two or
more processes for one mito-gene at least in a limited num-
ber of cases, whenever there is strong experimental evidence
that a protein or protein complex is contributing to two or
more mito-processes. We hope that the scientific commu-
nity working on mitochondria will help us further clean,
complete and correctly annotate our mito-interactomes by
using the FEEDBACK page.
The current version of mitoXplorer does not provide
mito-process enrichment analysis. Our reasoning behind
this decision was to allow users to mine their data in an
unbiased and detailed way, considering all mito-processes
rather than only focusing on enriched ones. In future re-
leases, we will consider adding information onmito-process
enrichment of a dataset to guide users in their analysis, for
example by visually highlighting enriched processes in the
Interactome View.
MitoXplorer has been optimized for mining expression
data and currently it is not meaningful to analyze mito-gene
mutations alone. We realize that this is a limitation when
considering large, population-wide studies. We will there-
fore consider implementing a visual data mining interface
that is specifically tailored for analyzing mito-gene muta-
tions alone in future versions of the software.
MitoXplorer expects users to provide data for which dif-
ferential expression analysis or mutation calling has already
been performed, as mitoXplorer was conceived as a visual
data mining platform. There are already many tools and
pipelines available to perform differential expression anal-
ysis and mutation calling, yet too few tools that allow in-
depth data mining, such as mitoXplorer. To make prior
data analysis as easy as possible for users, we provide a
pipeline for differential expression analysis andmutant call-
ing, which is available in our git-repository (https://gitlab.
com/habermannlab/mitox rnaseq pipeline/). Nevertheless,
we recognize that the potential heterogeneity of analyzed
data from different studies has limitations, especially con-
cerning comparative analysis between different projects.
MitoXplorer is integrating, clustering and visualizing nu-
merical data resulting from expression studies (transcrip-
tome, proteome), as well as mutation data. Thus, it is cur-
rently limited to analyzing mito-genes without offering the
ability to explore their embedding in a broader, cellular con-
text and thus to learn about potential regulatory mecha-
nisms of observed expression changes of mito-genes. There-
fore, in the next release of mitoXplorer, we plan to fully em-
bed mito-genes within the cellular gene regulatory, as well
as signaling network by adding information from epigenetic
studies (ChIP-seq, methylation data), as well as from the
cellular interactome. We will provide the tools to perform
enrichment analysis of observed transcription factors bind-
ing in the promoter regions of co-regulated mito-genes. We
will embed a method to analyze promoter regions of mito-
genes, as we have shown here for MRPS21, or to identify
targets of transcription factors as here demonstrated for
Hif1. Furthermore, we will make available network anal-
ysis methods such as viPEr (125) to explore the cellular
network regulating mito-genes. Other analysis methods we
plan to provide include correlation analysis, as well as cross-
species data mining. Depending on user requests, we could
also add the mitochondrial interactomes of other species.
As mitoXplorer stores the mitochondrial interactomes and
the associated -omics data in a MySQL database, all tech-
nical requirements for extending the functionalities of mi-
toXplorer are already implemented.
CONCLUSIONS
mitoXplorer is a powerful, web-based visual data min-
ing platform that allows users to in-depth analyze and vi-
sualize mutations and expression dynamics of mito-genes
and mito-processes by integrating a manually curated mi-
tochondrial interactome with -omics data in various tissues
and conditions of four model species, including human. We
used transcriptome and proteome data from cell lines with
trisomy 21 to demonstrate the value of mitoXplorer in ana-
lyzing in detail the expression dynamics of mito-genes and -
processes. We have used mitoXplorer to integrate these data
with publicly available datasets of patients with trisomy 21.
Using mitoXplorer for data mining, we predicted failure of
mitochondrial respiration in one of the trisomy 21 cell lines,
which we verified experimentally. Our results demonstrate
the power of a visual data mining platform such as mitoX-
plorer to explore expression dynamics of a specified mito-
gene set in a detailed and focused manner, leading to dis-
covery of underlying molecular mechanisms and providing
testable hypotheses for further experimental studies.
DATA AVAILABILITY
The mitoXplorer web-server is freely available at
http://mitoxplorer.ibdm.univ-mrs.fr/. The source code
of mitoXplorer is available at https://gitlab.com/
habermannlab/mitox. The pipeline for differential ex-
pression analysis and mutation calling of RNA-seq
data is available at https://gitlab.com/habermannlab/
mitox rnaseq pipeline. MitoMorph is freely available at
https://github.com/giocard/mitoMorph. RNA-seq data
published with this study are available via the Gene Ex-
pression Omnibus (GEO) database (accession number:
GSE131249).
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